Dr. Mehra Golshan Appointed Deputy Chief Medical Officer for Surgical Services at Smilow Cancer Hospital and Yale Cancer Center
Mehra Golshan, M.D., M.B.A., F.A.C.S., has been appointed the inaugural Deputy Chief Medical Officer for Surgical Services at Smilow Cancer Hospital and Yale Cancer Center, Professor of Surgery at Yale School of Medicine, and Interim Director of the Breast Center at Smilow Cancer Hospital.
Huntington and Parker receive new appointments at Smilow Cancer Hospital
Scott Huntington, M.D., M.P.H., assistant professor of Medicine (Hematology), has been named Medical Director for the Hematology Outpatient Program at Smilow Cancer Hospital and Terri Parker, M.D., assistant Professor of Medicine (Hematology), has been appointed the inaugural Assistant Medical Director for the Smilow Cancer Hospital Care Center in North Haven, which includes multiple myeloma and benign hematology care.
Sanft named Chief Patient Experience Officer at Smilow Cancer Hospital
Tara Sanft, M.D., associate professor of Medicine (Medical Oncology) and Director of the Smilow Cancer Hospital (SCH) Survivorship Clinic, has been appointed the inaugural Chief Patient Experience Officer at Yale Cancer Center (YCC) and SCH at Yale New Haven Hospital.
Smilow Cancer Hospital celebrates 10th anniversary
Smilow Cancer Hospital at Yale New Haven celebrates 10 years since it opened its doors to a new state-of-the-art inpatient and outpatient 500,000-square-foot cancer care facility. Since that day in October 2009, Smilow Cancer Hospital and Yale Cancer Center have risen to the top echelon as one of the nation’s comprehensive cancer research and care facilities, providing advanced care to patients and families and pioneering cancer research.
For Teens Living with Cancer, Keeping Life as 'Normal' as Possible
Yale New Haven Children's Hospital has opened the Lauren Telesz/Smilow Teen Center, to fill an important gap between pediatric and adult cancer care. The center dovetails with a larger goal to help improve survival rates for adolescents and young adults with cancer.
Smilow Cancer Hospital first in CT to perform new cancer treatment
Yale New Haven Health’s Smilow Cancer Hospital is the first hospital in Connecticut to use an innovative new immunotherapy called chimeric antigen receptor T-cell therapy, or CAR T-cell therapy, according to a press release from the hospital. “CAR T is an exciting new form of immunotherapy for certain blood cancers that is proving effective in patients with certain recurrent or resistant blood cancers,” said Stuart Seropian, the co-director of Smilow Cancer Hospital’s CAR T-Cell Therapy Program, in the press release.
Smilow Cancer Hospital first in Connecticut to perform CAR T-cell therapy
One of the most promising new generations of cancer treatment called Chimeric Antigen Receptor (CAR) T-cell therapy is now available for patients at Smilow Cancer Hospital. CAR T-cell therapy is groundbreaking immunotherapy that can cure patients with certain blood cancers who have run out of treatment options. In Connecticut, the treatment is only available at Smilow Cancer Hospital in partnership with Yale Cancer Center.
Clinical trials take innovative approach
Since their arrivals at Yale within the past six years, Joseph Paul Eder, MD, and Patricia LoRusso, DO, have overseen a sharp increase in the number of clinical trials conducted by the Phase I Program at Yale Cancer Center. Bench investigators and the clinicians who design and conduct early-phase trials interact regularly, each sharing knowledge with the other that both strengthens the basic science and brings new discoveries to patients more quickly and effectively.
Gift supports work on a stubborn cancer
Ginny Grunley became a patient of Roy S. Herbst, MD, PhD, after being diagnosed with a form of lung cancer associated with the EGFR gene mutation, also known as non-smoker’s lung cancer. Grunley and her husband Ken have given a million-dollar gift to support Herbst’s research.